The American College of Physicians (ACP) today released a new Clinical Guideline with recommendations for the appropriate use of high-flow nasal oxygen in hospitalized patients for initial or ...

Please provide your email address to receive an email when new articles are posted on . Patients with severe interstitial lung disease who received heated and humidified nasal high-flow oxygen therapy ...

Background and Aims: High flow (HF) nasal therapydelivers heated, humidified and blended oxygen/air via small calibre nasal cannulae at flow ratesof > 1L/min. Cold, non-humidified gases deliveredat HF ...

EXETER, N.H.--(BUSINESS WIRE)--Vapotherm, Inc. (NYSE: VAPO), a global medical technology company focused on the development and commercialization of its proprietary Vapotherm high velocity therapy® ...

(RTTNews) - Vapotherm, Inc. (VAPO) reported the presentation of an Investigator-initiated clinical trial, "High flow humidified oxygen as an early intervention in children with acute severe asthma - a ...

Vapotherm Inc (NASDAQ:VAPO) announced the presentation of an investigator-initiated clinical trial at the European Respiratory Society International Congress 2023, a "high flow humidified oxygen as an ...

Editor's note: Find the latest COVID-19 news and guidance in Medscape's Coronavirus Resource Center. COVID-19 patients with severe disease were significantly less likely to require mechanical ...

Please provide your email address to receive an email when new articles are posted on . Children aged 1 to 4 years with acute hypoxemic respiratory failure did not experience shorter hospital stays on ...

Increased respiratory patient illness, COVID-19, and product recalls have created a critical need for ventilators in the United States, said David Shockley, Movair’s CEO, in a recent company press ...

The high flow oxygen therapy (HFOT) market is expected to expand at a compound annual growth rate (CAGR) of approximately 7% during the forecast period. This growth is primarily driven by the ...